inewsmagazine

Startups

Nobel laureate Shuji Nakamura's Blue Laser Fusion files to register holders' shares for resale

The Goleta laser firm merged with a shell in September and raised about $34.1 million privately. With no market yet, resales under the filing are set at $27.50.

By Startups Desk ·

The short version

  1. Blue Laser Fusion filed on November 9, 2026, to register up to 2,353,422 shares for resale by existing holders, which brings it no money. Until a market develops, sales under the filing are fixed at $27.50 a share.
  2. It became an SEC reporting company on September 4, 2026, by merging with a shell, and in September and October sold 1,240,632 shares at $27.50 for about $34.1 million gross.
  3. The company says it has no market maker yet willing to apply for an OTC quotation, a step needed before its shares can trade there.
  4. It is pre-revenue: its net loss was $6.5 million in the nine months to September 30, 2026, and it held $33.0 million in cash at that date.

Blue Laser Fusion, an early-stage laser company in Goleta, California, whose chief executive is the Nobel laureate Shuji Nakamura, asked the Securities and Exchange Commission on November 9, 2026, to register up to 2,353,422 of its shares for resale by existing investors. There is no market for the stock. Until the shares are quoted on the OTCQB or another market develops, any sales under the filing must be at a fixed $27.50 a share, the price investors paid in a private placement completed in October.

The shares are made up of 1,240,632 sold in that placement; 1,000,000 held by shareholders of the shell company Blue Laser Fusion merged with, 995,000 of them by Lucius Partners, which the filing describes as an affiliate of the placement agent, Laidlaw & Company (UK); and 112,790 that Laidlaw can buy with warrants at $33.00. The holders may sell any, all or none of the shares, the filing says. The company receives nothing from the resales, but would collect $3,722,070 if Laidlaw exercised all its warrants for cash.

From shell company to SEC reporting company

Blue Laser Fusion reached public reporting status through a merger rather than an initial public offering. On September 4, 2026, a subsidiary of Unite Acquisition 2 Corp., a Delaware shell company incorporated in March 2022 with no operations, merged into the privately held Blue Laser Fusion. The shell took the Blue Laser Fusion name, and the private company's stock was converted into 5,993,834 shares. Lucius Partners, the shell's only common shareholder before the deal, agreed to cancel 4,000,000 of its shares, leaving 1,000,000 outstanding.

The private placement ran alongside the merger in three closings at $27.50: 910,265 shares right after the merger, 122,285 on September 30 and 208,082 on October 14. Together they raised about $34.1 million gross, or about $29.2 million after fees and costs, and the company announced completion on October 29. Laidlaw took a 10% commission plus a 2% expense allowance on money from investors it introduced, and 5% plus 1% on investors the company brought in. Before the merger, Blue Laser Fusion had raised about $38.2 million, net, from seed-stage preferred stock.

Blue Laser Fusion's funding, as stated in its November 9, 2026, registration statement
RoundWhenAmount
Series Seed-1 and Seed-2 preferred stockBefore the September 2026 mergerAbout $38.2 million net
Private placement, first closingSeptember 4, 2026910,265 shares at $27.50
Private placement, second closingSeptember 30, 2026122,285 shares at $27.50
Private placement, third closingOctober 14, 2026208,082 shares, about $5.7 million gross
Private placement, totalSeptember to October 20261,240,632 shares, about $34.1 million gross, $29.2 million net

What the company says it is building

The company is developing a pulsed laser design it calls GigaPulse, built on what it terms an optical enhancement cavity, for two markets: directed-energy defense systems and fusion power. It says its defense lasers are designed to deliver 100,000 times the peak power of conventional continuous-wave lasers, but it has not yet completed a full-scale 1-kilojoule demonstration or tested the laser in a defense application. Its fusion plans build on the ignition and net energy gain shown at Lawrence Livermore National Laboratory in December 2022; the filing warns that turning this into a commercial power plant presents substantial challenges.

Blue Laser Fusion says it has won research and development contracts from the U.S. Department of Energy and from Japan's Fusion Moonshot program, which it says are not commitments to buy commercial products, and holds more than 140 patents and patent applications. It runs research labs with Caltech and the Osaka University Blue Laser Fusion Institute. The filing identifies Nakamura, a co-founder, as a 2014 Nobel laureate for inventing efficient blue light-emitting diodes and says losing his services could materially harm the business. He is the largest shareholder, with about 24%, and he and the four other directors are named holders for shares they bought in the placement; his are 9,091 shares bought for $250,000.

Losses, cash and controls

The company has no revenue. It lost $6.5 million in the nine months to September 30, 2026, compared with $7.4 million a year earlier, and its accumulated deficit reached $27.6 million. It held $33.0 million in cash and cash equivalents at September 30, excluding the October closing. Management expects that cash to last at least 12 months but says it will need substantial additional funding to finish developing its lasers and fusion technology.

Blue Laser Fusion net losses, from its November 9, 2026, registration statement
PeriodNet loss
Year 2024$9.5 million
Year 2025$9.1 million
Nine months to September 30, 2025$7.4 million
Nine months to September 30, 2026$6.5 million

Management also concluded that the company's disclosure controls were not effective during the first nine months of 2026 because of material weaknesses. It cites too few employees to separate duties and the lack of a formal audit committee with a financial expert. Alongside the registration statement, it filed a current report recasting its 2024 and 2025 financial statements to reflect the merger.

What happens next

The SEC must declare the registration statement effective before the shares can be resold under it. A quotation on OTC Markets also needs a market maker to apply, and the company says it had none as of the filing date. It says it intends to seek either an OTC quotation or a listing on Nasdaq, the New York Stock Exchange or NYSE American once the registration is effective, and warns that a public market may not develop.

Sources

  1. Blue Laser Fusion, Inc., Form S-1 registration statement, filed November 9, 2026 U.S. Securities and Exchange Commission (EDGAR), November 9, 2026
  2. Blue Laser Fusion, Inc., filing index, accession no. 0001193125-26-453492 U.S. Securities and Exchange Commission (EDGAR), November 9, 2026
  3. Blue Laser Fusion, Inc., Form 8-K (recast 2024 and 2025 financial statements), filed November 9, 2026 U.S. Securities and Exchange Commission (EDGAR), November 9, 2026

Researched and drafted with AI assistance, then checked against the 3 sources above in a separate fact-check on November 11, 2026. Spotted an error? Tell us.

Read next

  1. Startups

    Parcel logistics firm CloudDepots files for a US IPO at $5 to $6 a share

    The California firm arranges deliveries for online sellers, a third of its revenue from China-based clients. First-half revenue rose 76% at a 2.8% gross margin.

    · 3 min read

  2. Startups

    Fort Robotics, a maker of safety controls for autonomous machines, files to go public through a SPAC

    Its merger filing shows revenue of $12.5 million and a net loss of $8.0 million in the nine months to September, with $1.7 million in cash.

    · 4 min read

  3. Startups

    Swiss dental company vVARDIS prices its US IPO at $18 a share, below its expected $21 to $24 range

    The maker of the drill-free Curodont cavity treatment sold 9,722,223 shares, more than the 8,333,334 it had offered, and says it is now listed on the NYSE.

    · 4 min read